U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819046) titled 'Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment' on Feb. 06.
Brief Summary: A randomized, single-site, parallel-group, prospective study of patients who are candidates for SLT, to study the effect of IOP change with Rocklatan vs artificial tears.
Study Start Date: Feb. 14
Study Type: OBSERVATIONAL
Condition:
Glaucoma
Intervention:
DRUG: Rocklatan
netarsudil and latanoprost ophthalmic solution 0.02%/0.005%
DRUG: Systane Ultra
artificial tears
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Colorado Ophthalmology Associates PC
Published b...